期刊文献+

大鼠血浆中辣椒素的HPLC-MS/MS测定 被引量:3

Analysis of capsaicin in rat plasma using liquid chromatography-tandem mass spectrometry
下载PDF
导出
摘要 目的建立一种简单方便的血浆中辣椒素浓度的液质联用检测方法(HPLC-MS/MS)。方法血浆样本100μl加入终浓度为50 ng/ml的维拉帕米(内标),用混合溶剂乙酸乙酯∶丙酮(85∶15)萃取后用安捷伦6460三重四级杆质谱系统进行分析。采用多反应监测(MRM)扫描方式,在ESI源正离子模式下,选择m/z 306→137作为辣椒素监测离子,m/z455→165为内标物监测离子。结果样品分析时间仅需1.5 min,方法线性范围在1.85~370 ng/ml(r=0.9997),最低检测限为1.85 ng/ml。辣椒素在三个质控浓度(3.7、37、370 ng/ml)检测下的提取回收率为77.34%,70.64%及78.02%。结论 HPLC-MS/MS灵敏、快速、准确,可应用于检测血浆中存在的微量辣椒素。 Objective To establish a simple high-performance liquid chromatography-tandem mass spectrometry(HPLC-MS) system for determination of capsaicin in rat plasma.Methods Rat plasma(100 μl) was extracted with mixed solvent(ethyl acetate∶acetone 85∶15) after addition of 50 ng/ml internal standard,and analyzed by Agilent 6460 Triple Quadrupole LC/MS system.The detection was performed with multiple reactions monitoring using electrospray ionization.The precursor/product ion transitions were monitored at m/z 306→137(+Ion mode) for capsaicin.Verapamil was used as the internal standard at m/ z455→165.Results The analysis time was only 1.5 min in the positive mode;the calibration curve was linear in the concentration range of 1.85-370 ng/ml.The lowest limit of quantification reached 1.85 ng/ml.The extraction recoveries were 77.34%,70.64% and 78.02% for the three quality control concentration levels(3.7,37,and 370 ng/ml),respectively.Conclusion The LC-MS/MS system is simple,accurate,reliable and time-saving for determination of trace amount of capsaicin in plasma.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第8期1165-1168,共4页 Journal of Southern Medical University
基金 国家自然科学基金(81173014) 广东省科技计划项目(2010B030700014) 南方医院院长基金(2010B015)~~
关键词 高效液相串联质谱 辣椒素 血浆 HPLC MS high-performance liquid chromatography-tandem mass spectrometry capsaicin plasma HPLC MS
  • 相关文献

参考文献15

  • 1Martini C,Yassen A,Olofsen E,et al.Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (QutenzTM) in diabetic neuropathic pain patients:detection of distinct response groups[J].J Pain Res,2012,5:51-9.
  • 2段炼,李国锋,孙亚彬,周望梅,李科.辣椒素经大鼠肠黏膜的区段透过特性[J].广东药学院学报,2010,26(1):13-16. 被引量:7
  • 3Matuszewski BK,Constanzer ML,Chavez-Eng CM.Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS[J].Anal Chem,2003,75(13):3019-30.
  • 4Caterina MJ,Schumacher MA,Tominaga M,et al.The capsaicin receptor:a heat-activated ion channel in the pain pathway[J].Nature,1997,389(6653):816-24.
  • 5Han Y,Tan TM,Lim LY.Effects of capsaicin on P-gp function and expression in Caco-2 cells[J].Biochem Pharmacol,2006,71(12):1727-34.
  • 6Tsukura Y,Mori M,Hirotani Y,et al.Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells[J].Biol Pharm Bull,2007,30(10):1982-6.
  • 7Nabekura T,Kamiyama S,Kitagawa S.Effects of dietary chemopreventive phytochemicals on P-glycoprotein function[J].Biochem Biophys Res Commun,2005,327(3):866-70.
  • 8Komori Y,Aiba T,Nakai C,et al.Capsaicin-induced increase of intestinal cefazolin absorption in rats[J].Drug Metab Pharmacokinet,2007,22(6):445-9.
  • 9Komori Y,Aiba T,Sugiyama R,et al.Effects of capsaicin on intestinal cephalexin absorption in rats[J].Biol Pharm Bull,2007,30(3):547-51.
  • 10Rumsfield JA,West DP.Topical capsaicin in dermatologic and peripheral pain disorders[J].DICP,1991,25(4):381-7.

二级参考文献47

共引文献33

同被引文献25

  • 1梁晨,韩盛玺.辣椒素临床应用的研究进展[J].华西药学杂志,2008,23(2):185-187. 被引量:17
  • 2李欣玮,孙立新,林晓宏,郑利强.固体脂质纳米粒作为药物载体[J].化学进展,2007,19(1):87-92. 被引量:30
  • 3徐兵,李昕,张莉.辣椒素药理作用的研究进展[J].中南药学,2007,5(6):542-545. 被引量:13
  • 4Martini C, Yassen A, Olofsen E, et al. Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Quten- za) in diabetic neuropathic pain patients: detection of distinct response groups[J ]. J Pain Res,2012, 5(3):51-59.
  • 5Anandakumar P, Kamaraj S, Jagan S, et al. Capsaicin allevi- ates the imbalance in xenobiotic metabolizing enzymes and tu- mor markers during experimental lung tumorigenesis [J]. Mol Cell Biochem, 2009,331 ( 1/2 ): 135-143.
  • 6Duan L, Yan Y,Sun YB,et al.Contribution of TRPV1 and mul- tidrug resistance proteins in the permeation of capsaicin across different intestinal regions [J]. Int J Pharm, 2013, 445(1/2): 134-140.
  • 7Nimmerfall F, Rosenthaler J. Significance of the goblet-cell rnuein layer, the outermost luminal barrier to passage through the gut wall [J]. Biochem Biophys Res Commun, 1980,94(3): 960-966.
  • 8SHARMA S K, VIJ A S, SHARMA M. Mechanisms and clinical uses of capsaicin[J]. Eur J Pharmacol, 2013, 7(20):55-62.
  • 9WANG Y, HUAN D C, LU B. Characteristics and problems of solidlipid nanoparticles [J].解放军药学学报, 2006, 22(1): 51-54.
  • 10SOUTO E B, MILLER R H.Investigation of the factors influencing the incorporation of cptrinazole in SLN and NLC prepared by hot high pressure homogenization[J]. J Microencapsul,2006,23(4):377-388.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部